CSPC PHARMACEUT.GR. financial statements, including revenue, expenses, profit, and loss
The total revenue of CVG for the last semiannual is 1.93 B EUR, and it's 9.45% lower compared to the previous semiannual. The net income of H2 23 is 364.21 M EUR.